David J. Allsop

1.5k total citations
30 papers, 1.1k citations indexed

About

David J. Allsop is a scholar working on Pharmacology, Psychiatry and Mental health and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, David J. Allsop has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 10 papers in Psychiatry and Mental health and 8 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in David J. Allsop's work include Cannabis and Cannabinoid Research (18 papers), Animal Behavior and Reproduction (8 papers) and Bipolar Disorder and Treatment (7 papers). David J. Allsop is often cited by papers focused on Cannabis and Cannabinoid Research (18 papers), Animal Behavior and Reproduction (8 papers) and Bipolar Disorder and Treatment (7 papers). David J. Allsop collaborates with scholars based in Australia, United Kingdom and United States. David J. Allsop's co-authors include Stuart A. West, Jan Copeland, Melissa M. Norberg, Iain S. McGregor, Shanlin Fu, Nicholas Lintzeris, Alan J. Budney, Adrian Dunlop, Craig Sadler and Gonzalo Rivas and has published in prestigious journals such as Nature, PLoS ONE and Scientific Reports.

In The Last Decade

David J. Allsop

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by David J. Allsop

Since Specialization

Citations

This map shows the geographic impact of David J. Allsop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Allsop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Allsop more than expected).

Fields of papers citing papers by David J. Allsop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Allsop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Allsop. The network helps show where David J. Allsop may publish in the future.

Co-authorship network of co-authors of David J. Allsop

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Allsop. A scholar is included among the top collaborators of David J. Allsop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Allsop. David J. Allsop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV) 2018 ·BMJ Open ·(unknown), Annette Tognela, Paul Haber, Martin R. Stockler, Nicholas Lintzeris, John Simes, Iain S. McGregor, Ian Olver, David J. Allsop, Craig Gedye, Adrienne Kirby, Rachael L. Morton, Peter Fox, Stephen Clarke, Karen Briscoe, Morteza Aghmesheh, Nicole Wong, (unknown), (unknown), Peter Grimison	19
2	Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice 2018 ·Scientific Reports ·Paul J. Meakin, (unknown), Gemma Montagut, David J. Allsop, (unknown), (unknown), (unknown), (unknown), Alison D. McNeilly, (unknown), Yuru Liu, (unknown), J. Kim Dale, Lora K. Heisler, Rory J. McCrimmon, Michael L.J. Ashford	31
3	Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV) 2018 ·Annals of Oncology ·(unknown), Annette Tognela, Paul Haber, Martin R. Stockler, Nicholas Lintzeris, John Simes, Iain S. McGregor, Ian Olver, David J. Allsop, Craig Gedye, Adrienne Kirby, Rachael L. Morton, Karen Briscoe, Peter Fox, Morteza Aghmesheh, Nicole Wong, (unknown), Anh Tran, (unknown), Peter Grimison	4
4	Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol 2018 ·BMC Psychiatry ·(unknown), Anjali Bhardwaj, David J. Allsop, Jan Copeland, Iain S. McGregor, Adrian Dunlop, Marian Shanahan, Raimondo Bruno, Nghi Phung, Mark Montebello, Craig Sadler, Jessica Gugusheff, (unknown), (unknown), Nicholas Lintzeris	16
5	Cognitive, physical, and mental health outcomes between long-term cannabis and tobacco users 2017 ·Addictive Behaviors ·(unknown), Raimondo Bruno, Jason W. Johnston, Allison Matthews, Iain S. McGregor, David J. Allsop, Nicholas Lintzeris	27
6	An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use 2017 ·Epilepsy & Behavior ·Anastasia Suraev, (unknown), Michael T. Bowen, David J. Allsop, Iain S. McGregor, Carol A. Ireland, Nicholas Lintzeris	53
7	The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence 2015 ·Journal of Clinical Sleep Medicine ·David J. Allsop, Delwyn J. Bartlett, Jennifer Johnston, (unknown), Adam Winstock, Iain S. McGregor, Nicholas Lintzeris	15
8	Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting 2014 ·Psychopharmacology ·Jennifer Johnston, Nicholas Lintzeris, David J. Allsop, Anastasia Suraev, Jessica Booth, Dean S. Carson, (unknown), Adam Winstock, Iain S. McGregor	29
9	Changes in cigarette and alcohol use during cannabis abstinence 2014 ·Drug and Alcohol Dependence ·David J. Allsop, Adrian Dunlop, Craig Sadler, Gonzalo Rivas, Iain S. McGregor, Jan Copeland	44
10	The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC–MS/MS 2014 ·Forensic Science International ·Anna Molnár, Shanlin Fu, John H. Lewis, David J. Allsop, Jan Copeland	17
11	Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences 2014 ·Psychopharmacology ·Alexander Wong, (unknown), Kieron Rooney, Callum Hicks, David J. Allsop, Jonathon C. Arnold, Iain S. McGregor	7
12	The impact of Sativex® on cognitive function during treatment for cannabis withdrawal 2014 ·Drug and Alcohol Dependence ·Raimondo Bruno, David J. Allsop, Jan Copeland, Nicholas Lintzeris, Iain S. McGregor, Melissa M. Norberg, Adrian Dunlop, Mark Montebello, Craig Sadler, Richard Holland, Gonzalo Rivas	1
13	Quantifying the Clinical Significance of Cannabis Withdrawal 2012 ·PLoS ONE ·David J. Allsop, Jan Copeland, Melissa M. Norberg, Shanlin Fu, Anna Molnár, John H. Lewis, Alan J. Budney	125
14	The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress 2011 ·Drug and Alcohol Dependence ·David J. Allsop, Melissa M. Norberg, Jan Copeland, Shanlin Fu, Alan J. Budney	153
15	A Dimensionless Invariant for Relative Size at Sex Change in Animals: Explanation and Implications 2005 ·The American Naturalist ·Andy Gardner, David J. Allsop, Eric L. Charnov, Stuart A. West	20
16	Sex allocation in the sex-changing marine goby, Coryphopterus personatus, on atoll-fringing reefs 2004 ·Evolutionary ecology research ·David J. Allsop, Stuart A. West	10
17	Sex change and relative body size in animals (reply) 2004 ·Nature ·Stuart A. West, David J. Allsop	1
18	SEX-RATIO EVOLUTION IN SEX CHANGING ANIMALS 2004 ·Evolution ·David J. Allsop, Stuart A. West	79
19	SEX-RATIO EVOLUTION IN SEX CHANGING ANIMALS 2004 ·Evolution ·David J. Allsop, Stuart A. West	8
20	Changing sex at the same relative body size 2003 ·Nature ·David J. Allsop, Stuart A. West	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact